Determinants of Patients' Uptake of Therapeutic Education Programme
NCT ID: NCT03255863
Last Updated: 2022-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
459 participants
INTERVENTIONAL
2017-12-20
2020-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary aims are as follows:
1. To test whether the way TPE is presented to patients impact patients' decision to uptake TPE. The way TPE is presented comprises the time between diagnosis and the proposal of TPE, whether patient is a remission or crisis period in the disease, the time between the proposal and the next TPE session, and what is said by healthcare professionals to present TPE.
2. To test whether healthcare professionals' empathy impact patients' decision to participate in TPE
3. To test whether patients' intention to participate in TPE will predict their actual participation.
The ultimate goal of the study is to identify patients whose beliefs will not favor participation in TPE in order to accompany those patients more carefully. Best practices will be proposed according the results.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Classification of Patient Therapeutic Education Programs Components : Etude CONCErTo
NCT02717182
Impact of a Therapeutic Education Program of Patient on the Evolution of the Cardiovascular Chronic Disease
NCT02819791
Format of Patient Education for Different Sociodemographic Groups
NCT02961517
Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals.
NCT06748118
Learning Theory Patient Education for Anticoagulants
NCT06138184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Questionnaire
Auto and hetero questionnaire
Questionnaire
Patient Self reported questionnaire filled in.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Patient Self reported questionnaire filled in.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Belong to a social security scheme
* Pregnant women to whom TPE for gestational diabetes is proposed
Exclusion Criteria
* Inpatients
* Patients for whom TPE is coupled with rehabilitation
* Psychiatric disorders
* Patients who cannot give informed consent
* Patients in jail
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, France
OTHER_GOV
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maryline Bourgoin
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Claude Huriez, CHU
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A02057-44
Identifier Type: OTHER
Identifier Source: secondary_id
2015_70
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.